Forum Archive Index - July 2003

["G Stolwyk" <stolwyk@wave.co.nz>]

It is not that easy to obtain Phenoxodiol.

 

I gave a lady with Ovarian Cancer a contact address and got this reply:

 

"This is what I learned by going to Novogen.com. I got the list of contacts. I called the contact person in USA, Mr David Shoen. He informed me that the only way to get phonox is through clinical trial since the study is at phase II.

 

Once they open Phase III there is a possibility to obtain the drug out side of the clinical trial.

 

I also used the E-mail address to contact Ron Erratt but David Sheon replied. I contacted Yale regarding their future clinical trials.

 

The person that I was referred to, Rene Luongo was not available. I spoke with Anita who seemed to be involved in the project.

 

She stated another phase II will be open in fall. It may be a combination of one chemo agent and Phenox. Gerry If you have any further suggestion please let me know".
____________________________________

 

I suggested she register at YALE:

 

The idea is to get oneself put on the LIST -See below:

 

The YALE Patient Enrollment Office:

 

I have 2 addresses here:

 

Anita Makkenchery, E-mail Address(es): anita_makk@yahoo.com

 

The actual Enrollment office:

 

renee.luongo@yale.edu , Manager, Yale University School of Medicine, at 203-737-5225.

 

For more information on phenoxodiol, visit www.marshalledwardsinc.com or www.novogen.com.

 

+++++++++++++++++++++++++++++++++++++

 

18 June: From Yale-ENROLLMENT OFFICE:

 

PHENOXODIOL-GYN. CANCER-PHASE II

 

Dear Gerry: > > We have currently completed enrollment for this > > trial. > > > Although if she would like to leave your contact > > information, we can consider you for future > trials. > > > > We are in the process of creating a website which > > will > > have updates about this phenoxodiol trials as well > > as > > future trials. Once I get her postal address, I > can > > add that to the contact information form, and keep > > it > > on file if she is still interested. > > > > Thank you for your interest. > > > > Sincerely > > > > Anita Makkenchery > > > > Research Associate
______________________

 

Comment: The well informed were expecting a Combo of Phenoxodiol and Cisplatin (P+C) to start in Oct.

 

Gerry